{"id":52937,"date":"2019-11-28T15:05:02","date_gmt":"2019-11-28T15:05:02","guid":{"rendered":"https:\/\/kc.multimarketing.dev\/what-is-the-current-legal-framework-of-medical-cannabis-in-france\/"},"modified":"2019-11-28T15:05:02","modified_gmt":"2019-11-28T15:05:02","slug":"what-is-the-current-legal-framework-of-medical-cannabis-in-france","status":"publish","type":"post","link":"https:\/\/www.kalapa-clinic.com\/en\/what-is-the-current-legal-framework-of-medical-cannabis-in-france\/","title":{"rendered":"What is the current legal framework of medical cannabis in France?"},"content":{"rendered":"

Should cannabis be legalized? The issue has never been more topical. In April 2019, the French Observatory for Drugs and Drug Addiction published a survey<\/a> conducted at the end of 2018: 45% of French people “agree for the legalization of cannabis” and 91% believe that “cannabis consumption could be prescribed by doctors for certain serious or chronic diseases”.[1]<\/a><\/p>\n

The current legislation on the consumption, possession, purchase or sale of cannabis is in any case not simple. Many texts are to be considered and it is difficult to understand what is legal from what is not. Let’s make a review.<\/p>\n

French law prohibits cannabis, its extracts and resins<\/h2>\n

The decree of 22 February 1990<\/a> classifies cannabis, cannabis resin and tetrahydrocannabinol (THC) as narcotic drugs.[2]<\/a><\/p>\n

According to article L. 3421-1<\/a> of the French Public Health Code (FPHC), “The illicit use of any of the substances or plants classified as narcotic drugs is punishable by one year’s imprisonment<\/strong> and a fine of 3750 euros<\/strong>. Persons guilty of this offence shall also be required, as an additional penalty, to complete a training course to raise awareness of the dangers of the use of narcotic substances.[3]<\/a><\/p>\n

In practice, a circular on the fight against drug addiction and dependences<\/a> published in April 2005 recommends an “adapted and diversified judicial response towards users” depending on the case. Age, personality, use, and consumption habits are taken into account. “The implementation of criminal proceedings shall be exceptional<\/strong> and shall be reserved for repeat offenders and users who refuse to comply with alternative measures ordered by the public prosecutor’s office”. Closings without action, if they are not followed by a warning or a reminder to the law, must be excluded.[4]<\/a><\/p>\n

French law does not yet distinguish therapeutic from recreational use of cannabinoids. Consuming cannabis for therapeutic purposes is therefore punished in the same way as recreational use.<\/p>\n

In accordance with Article R. 5132-86<\/a> FPHC, the production<\/strong>, manufacture<\/strong>, transport<\/strong>, import<\/strong>, possession<\/strong>, offer<\/strong>, transfer<\/strong>, acquisition<\/strong> or use<\/strong> of cannabis, its plant, resin and their derivatives is also prohibited. The same applies to tetrahydrocannabinols, except for delta-9-tetrahydrocannabinol (THC) and some of its derivatives.<\/p>\n

Since 2018, questions about cannabis use have been regularly asked in the National Assembly. A bill<\/a> on the controlled legalization of the production, sale and consumption of cannabis (therapeutic or recreational) was even tabled on July 2, 2019 by environmentalist MP Fran\u00e7ois-Michel Lambert.[5]<\/a><\/p>\n

Yet, some derogations authorices cannabis in some cases<\/h3>\n

The article R. 5132-86 FHPC also allows the Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) [editor\u2019s note: Medication and Health Products Safety National Agency<\/em>] to grant exemptions<\/strong> in the context of research, control and manufacture of derivatives.<\/p>\n

In addition, “The cultivation<\/strong>, import<\/strong>, export<\/strong> and industrial and commercial use<\/strong> of cannabis varieties without stunning properties or products containing such varieties may be authorized, on the proposal of the Director General of the Agency, by order of the Departments responsible for agriculture, customs, industry and health. \u00bb[6]<\/a><\/p>\n

Article 1 of the decree of 22 August 1990<\/a> implementing Article R. 5132-86 FHPC for cannabis provides details of these authorisations:<\/p>\n

“the cultivation, import, export and industrial and commercial use (fibre<\/strong> and seed<\/strong>) of Cannabis sativa L<\/strong> [editor\u2019s note: hemp]<\/em> varieties are authorised meeting the following criteria:<\/p>\n